EMAIL THIS PAGE TO A FRIEND

Food & function

Sesamin suppresses macrophage-derived chemokine expression in human monocytes via epigenetic regulation.


PMID 25117529

Abstract

Chemokines play important roles in the pathogenesis of asthmatic inflammation. Sesamin, a class of phytoestrogen isolated from sesame seed Sesamum indicum, is recently regarded as an anti-inflammatory agent. However, the effects of sesamin on asthma-related chemokines are unknown. To this end, we investigated the effects of sesamin on the expression interferon-γ-inducible protein-10 (IP-10/CXCL10), macrophage-derived chemokine (MDC/CCL22), growth-related oncogene-α (GRO-α/CXCL1) and tumor necrosis factor (TNF)-α in human monocytes. Cells were pretreated with sesamin before lipopolysaccharide (LPS) stimulation. IP-10, MDC, GRO-α and TNF-α were measured by ELISA. Involved receptors and intracellular signaling were investigated by receptor antagonists, pathway inhibitors, western blotting and chromatin immunoprecipitation. Sesamin suppressed LPS-induced MDC in THP-1 and human primary monocytes. Sesamin suppressed LPS-induced IP-10 in THP-1 cells, but not human primary monocytes. Sesamin had no effects on LPS-induced GRO-α and TNF-α expression in THP-1 and human primary monocytes. The suppressive effect of sesamin on MDC was reversed by the estrogen receptor (ER) and peroxisomal proliferator-activated receptor (PPAR)-α antagonists. Sesamin suppressed LPS-induced phosphorylation of mitogen-activated protein kinase (MAPK)-p38 and nuclear factor kappa B (NFκB)-p65. Sesamin suppressed histone H3/H4 acetylation in the MDC promoter region. Sesamin suppressed LPS-induced MDC expression via the ER, the PPAR-α, the MAPK-p38 pathway, the NFκB-p65 pathway and the epigenetic regulation. Sesamin may have therapeutic potential in preventing and treating asthma.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

642355
2-Chloro-5-nitrobenzanilide, 97%
C13H9ClN2O3
SAB1100404
Anti-RELA (51-65) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB4300294
Anti-RELA (Ab-254) antibody produced in rabbit, affinity isolated antibody
SAB4300295
Anti-RELA (Ab-276) antibody produced in rabbit, affinity isolated antibody
SAB4300506
Anti-RELA (Ab-311) antibody produced in rabbit, affinity isolated antibody
SAB4300296
Anti-RELA (Ab-435) antibody produced in rabbit, affinity isolated antibody
SAB4300297
Anti-RELA (Ab-468) antibody produced in rabbit, affinity isolated antibody
SAB4300442
Anti-RELA (Ab-505) antibody produced in rabbit, affinity isolated antibody
SAB4300469
Anti-RELA (Ab-529) antibody produced in rabbit, affinity isolated antibody
SAB4300298
Anti-RELA (Ab-536) antibody produced in rabbit, affinity isolated antibody
AV100779
Anti-RELA antibody produced in rabbit, IgG fraction of antiserum
M6191
GW9662, >98% (HPLC)
C13H9ClN2O3
SAB1404309
Monoclonal Anti-RELA antibody produced in mouse, clone 8G3, ascites fluid
S9314
Sesamin, ≥95%, crystalline
C20H18O6
59867
Sesamin, analytical standard
C20H18O6
SAB2101980
Anti-RELA antibody produced in rabbit, affinity isolated antibody
SAB2103066
Anti-RELA antibody produced in rabbit, affinity isolated antibody
SAB5300389
Monoclonal Anti-RELA antibody produced in mouse, clone 6H7, ascites fluid